In B-CLL, activated CD4+ Th cells increase miR-181b expression in B-CLL via CD40-CD40L signaling, mediate a decrease in IL-10 expression, and further enhance the cytotoxicity of CD8+ CTLs [141]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.